159 related articles for article (PubMed ID: 16797247)
1. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
Samowitz WS; Wolff RK; Curtin K; Sweeney C; Ma KN; Andersen K; Levin TR; Slattery ML
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):894-901. PubMed ID: 16797247
[TBL] [Abstract][Full Text] [Related]
2. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.
Chan AT; Tranah GJ; Giovannucci EL; Hunter DJ; Fuchs CS
J Natl Cancer Inst; 2005 Mar; 97(6):457-60. PubMed ID: 15770010
[TBL] [Abstract][Full Text] [Related]
4. No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma.
McGreavey LE; Turner F; Smith G; Boylan K; Timothy Bishop D; Forman D; Roland Wolf C; Barrett JH;
Pharmacogenet Genomics; 2005 Oct; 15(10):713-21. PubMed ID: 16141797
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence.
Hubner RA; Muir KR; Liu JF; Logan RF; Grainge M; Armitage N; Shepherd V; Popat S; Houlston RS;
Clin Cancer Res; 2006 Nov; 12(21):6585-9. PubMed ID: 17085674
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid.
van Oijen MG; Huybers S; Peters WH; Drenth JP; Laheij RJ; Verheugt FW; Jansen JB
Br J Clin Pharmacol; 2005 Dec; 60(6):623-8. PubMed ID: 16305586
[TBL] [Abstract][Full Text] [Related]
8. Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain.
Fortuny J; Kogevinas M; Garcia-Closas M; Real FX; Tardón A; Garcia-Closas R; Serra C; Carrato A; Lloreta J; Rothman N; Villanueva C; Dosemeci M; Malats N; Silverman D
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1696-702. PubMed ID: 16985032
[TBL] [Abstract][Full Text] [Related]
9. No modification of the beneficial effect of NSAIDs on colorectal cancer by CYP2C9 genotype.
Siemes C; Eijgelsheim M; Dieleman JP; van Schaik RH; Uitterlinden AG; van Duijn CM; Hofman A; Coebergh JW; Stricker BH; Visser LE
Neth J Med; 2009 Apr; 67(4):134-41. PubMed ID: 19581657
[TBL] [Abstract][Full Text] [Related]
10. Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway.
Slattery ML; Samowitz W; Hoffman M; Ma KN; Levin TR; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):538-45. PubMed ID: 15066917
[TBL] [Abstract][Full Text] [Related]
11. No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.
Thompson CL; Plummer SJ; Merkulova A; Cheng I; Tucker TC; Casey G; Li L
World J Gastroenterol; 2009 May; 15(18):2240-4. PubMed ID: 19437564
[TBL] [Abstract][Full Text] [Related]
12. The Implication of the Polymorphisms of COX-1, UGT1A6, and CYP2C9 among Cardiovascular Disease (CVD) Patients Treated with Aspirin.
Jalil NJ; Bannur Z; Derahman A; Maskon O; Darinah N; Hamidi H; Gunasekaran OA; Rafizi M; Azreen NI; Kek TL; Salleh MZ
J Pharm Pharm Sci; 2015; 18(3):474-83. PubMed ID: 26517138
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
[TBL] [Abstract][Full Text] [Related]
14. Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants.
Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH
Clin Pharmacol Ther; 2005 Jun; 77(6):479-85. PubMed ID: 15961979
[TBL] [Abstract][Full Text] [Related]
15. Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study.
Tranah GJ; Chan AT; Giovannucci E; Ma J; Fuchs C; Hunter DJ
Mol Carcinog; 2005 Sep; 44(1):21-30. PubMed ID: 15924351
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.
Scherer D; Koepl LM; Poole EM; Balavarca Y; Xiao L; Baron JA; Hsu L; Coghill AE; Campbell PT; Kleinstein SE; Figueiredo JC; Lampe JW; Buck K; Potter JD; Kulmacz RJ; Jenkins MA; Hopper JL; Win AK; Newcomb PA; Ulrich CM; Makar KW
Genes Chromosomes Cancer; 2014 Jul; 53(7):568-78. PubMed ID: 24677636
[TBL] [Abstract][Full Text] [Related]
17. Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy.
Guo Y; Hu C; He X; Qiu F; Zhao L
Drug Metab Pharmacokinet; 2012; 27(5):536-42. PubMed ID: 23099353
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
Pharmacogenet Genomics; 2009 Feb; 19(2):113-20. PubMed ID: 19077918
[TBL] [Abstract][Full Text] [Related]
19. A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.
Cross JT; Poole EM; Ulrich CM
Pharmacogenomics J; 2008 Aug; 8(4):237-47. PubMed ID: 18195728
[TBL] [Abstract][Full Text] [Related]
20. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
